- Home
- GALT vs VERI Comparison
GALT vs VERI Comparison
Compare GALT & VERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- VERI
- Stock Information
- Founded
- GALT 2000
- VERI 2014
- Country
- GALT United States
- VERI United States
- Employees
- GALT N/A
- VERI N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- VERI EDP Services
- Sector
- GALT Health Care
- VERI Technology
- Exchange
- GALT Nasdaq
- VERI Nasdaq
- Market Cap
- GALT 86.0M
- VERI 91.5M
- IPO Year
- GALT N/A
- VERI 2017
- Fundamental
- Price
- GALT $1.38
- VERI $1.81
- Analyst Decision
- GALT Hold
- VERI Strong Buy
- Analyst Count
- GALT 1
- VERI 3
- Target Price
- GALT N/A
- VERI $4.17
- AVG Volume (30 Days)
- GALT 177.7K
- VERI 452.4K
- Earning Date
- GALT 05-19-2025
- VERI 05-08-2025
- Dividend Yield
- GALT N/A
- VERI N/A
- EPS Growth
- GALT N/A
- VERI N/A
- EPS
- GALT N/A
- VERI N/A
- Revenue
- GALT N/A
- VERI $90,937,000.00
- Revenue This Year
- GALT N/A
- VERI $23.41
- Revenue Next Year
- GALT N/A
- VERI $26.79
- P/E Ratio
- GALT N/A
- VERI N/A
- Revenue Growth
- GALT N/A
- VERI N/A
- 52 Week Low
- GALT $0.73
- VERI $1.86
- 52 Week High
- GALT $3.41
- VERI $5.64
- Technical
- Relative Strength Index (RSI)
- GALT 49.81
- VERI 35.04
- Support Level
- GALT $1.26
- VERI $1.94
- Resistance Level
- GALT $1.63
- VERI $2.05
- Average True Range (ATR)
- GALT 0.13
- VERI 0.12
- MACD
- GALT 0.02
- VERI -0.01
- Stochastic Oscillator
- GALT 37.50
- VERI 6.90
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About VERI Veritone Inc.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel, and India.